Circulating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinoma

PURPOSE: Mutations in the IDH1 and IDH2 (IDH1/2) genes occur in ~20% of intrahepatic cholangiocarcinoma (ICC) and lead to accumulation of 2-hydroxyglutarate (2HG) in the tumor tissue. However, it remains unknown whether IDH1/2 mutations can lead to high levels of 2HG circulating in the blood and whe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Borger, Darrell R., Goyal, Lipika, Yau, Thomas, Poon, Ronnie T., Ancukiewicz, Marek, Deshpande, Vikram, Christiani, David C., Liebman, Hannah M., Yang, Hua, Kim, Hyeryun, Yen, Katharine, Faris, Jason E., Iafrate, A. John, Kwak, Eunice L., Clark, Jeffrey W., Allen, Jill N., Blaszkowsky, Lawrence S., Murphy, Janet E., Saha, Supriya K., Hong, Theodore S., Wo, Jennifer Y., Ferrone, Cristina R., Tanabe, Kenneth K., Bardeesy, Nabeel, Straley, Kimberly S., Agresta, Sam, Schenkein, David P., Ellisen, Leif W., Ryan, David P., Zhu, Andrew X.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4107454/
https://ncbi.nlm.nih.gov/pubmed/24478380
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-13-2649
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados